CLYM
Price
$1.85
Change
-$0.06 (-3.14%)
Updated
Nov 19, 01:35 PM (EDT)
Capitalization
129.89M
110 days until earnings call
Intraday BUY SELL Signals
KYTX
Price
$8.07
Change
+$0.24 (+3.07%)
Updated
Nov 19, 01:48 PM (EDT)
Capitalization
343.36M
Intraday BUY SELL Signals
Interact to see
Advertisement

CLYM vs KYTX

Header iconCLYM vs KYTX Comparison
Open Charts CLYM vs KYTXBanner chart's image
Climb Bio
Price$1.85
Change-$0.06 (-3.14%)
Volume$200
Capitalization129.89M
Kyverna Therapeutics
Price$8.07
Change+$0.24 (+3.07%)
Volume$412
Capitalization343.36M
CLYM vs KYTX Comparison Chart in %
CLYM
Daily Signal:
Gain/Loss:
KYTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CLYM vs. KYTX commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLYM is a Hold and KYTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (CLYM: $1.90 vs. KYTX: $7.84)
Brand notoriety: CLYM and KYTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLYM: 59% vs. KYTX: 208%
Market capitalization -- CLYM: $129.89M vs. KYTX: $343.36M
CLYM [@Biotechnology] is valued at $129.89M. KYTX’s [@Biotechnology] market capitalization is $343.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLYM’s FA Score shows that 1 FA rating(s) are green whileKYTX’s FA Score has 0 green FA rating(s).

  • CLYM’s FA Score: 1 green, 4 red.
  • KYTX’s FA Score: 0 green, 5 red.
According to our system of comparison, CLYM is a better buy in the long-term than KYTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLYM’s TA Score shows that 3 TA indicator(s) are bullish while KYTX’s TA Score has 4 bullish TA indicator(s).

  • CLYM’s TA Score: 3 bullish, 5 bearish.
  • KYTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, KYTX is a better buy in the short-term than CLYM.

Price Growth

CLYM (@Biotechnology) experienced а +0.26% price change this week, while KYTX (@Biotechnology) price change was +12.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.28%. For the same industry, the average monthly price growth was -5.78%, and the average quarterly price growth was +64.80%.

Reported Earning Dates

CLYM is expected to report earnings on Mar 09, 2026.

Industries' Descriptions

@Biotechnology (-2.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYTX($343M) has a higher market cap than CLYM($130M). KYTX YTD gains are higher at: 109.626 vs. CLYM (5.833). CLYM has higher annual earnings (EBITDA): -4.68M vs. KYTX (-156.46M). KYTX has more cash in the bank: 212M vs. CLYM (84.7M). CLYM has less debt than KYTX: CLYM (639K) vs KYTX (5.92M). CLYM (0) and KYTX (0) have equivalent revenues.
CLYMKYTXCLYM / KYTX
Capitalization130M343M38%
EBITDA-4.68M-156.46M3%
Gain YTD5.833109.6265%
P/E RatioN/AN/A-
Revenue00-
Total Cash84.7M212M40%
Total Debt639K5.92M11%
TECHNICAL ANALYSIS
Technical Analysis
CLYMKYTX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CLYM
Daily Signal:
Gain/Loss:
KYTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HYDTF3.530.03
+0.71%
Hydreight Technologies Inc
BMNM1.75N/A
N/A
Bimini Capital Management, Inc.
CEVMF90.00N/A
N/A
CTS Eventim AG & Co. KGAA
ILKAY21.90N/A
N/A
Iluka Resources Ltd.
NONOF46.35-0.90
-1.90%
Novo-Nordisk A/S

CLYM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLYM has been loosely correlated with KYTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYM jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLYM
1D Price
Change %
CLYM100%
+1.33%
KYTX - CLYM
43%
Loosely correlated
+9.50%
PDSB - CLYM
41%
Loosely correlated
+1.52%
IPSC - CLYM
41%
Loosely correlated
+1.99%
RXRX - CLYM
40%
Loosely correlated
+0.97%
PRME - CLYM
39%
Loosely correlated
-7.59%
More

KYTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYTX has been loosely correlated with IPSC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if KYTX jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYTX
1D Price
Change %
KYTX100%
+9.50%
IPSC - KYTX
45%
Loosely correlated
+1.99%
RXRX - KYTX
44%
Loosely correlated
+0.97%
CLYM - KYTX
43%
Loosely correlated
+1.33%
BEAM - KYTX
43%
Loosely correlated
-0.36%
CRSP - KYTX
42%
Loosely correlated
-3.34%
More